www.fdanews.com/articles/132201-roche-ends-deal-with-ligand
Roche Ends Deal With Ligand
November 26, 2010
San Diego’s Ligand Pharmaceuticals said that Roche has terminated their collaboration and licensing agreement to develop a treatment for hepatitis C, according to a regulatory filing.
Xconomy
Xconomy